Reducing oxygen levels in the gastrointestinal tract
AssigneeNortheastern University
InventorsKim LEWIS, Norman PITT, Madeleine MORRISSETTE
Life of this patent
Estimating the term…
Abstract
The present disclosure is directed towards a method of treating a disease or condition associated with gut inflammation. The present disclosure comprises administering, to a patient in need thereof, a composition comprising oxygen-scavenging membrane fragments or membrane vesicles. In some embodiments, membrane vesicles are derived from bacteria. In some embodiments, membrane vesicles are derived from the cytoplasmic membranes of Escherichia coli, Salmonella typhimurium, Gluconobacter oxydans, Pseudomonas aeruginosa, or Acetobacter.
Claims18
A method of treating a disease or condition associated with gut inflammation comprising administering, to a patient in need thereof, a therapeutically effective amount of a composition comprising oxygen-scavenging membrane fragments and/or membrane vesicles, or a pharmaceutically acceptable salt, solvate, hydrate, cocrystal, or prodrug thereof.
Dependencies are inferred from the claim text.